Skip to main content
. 2018 Nov 5;35(4):299–308. doi: 10.1055/s-0038-1673422

Table 1. Outcomes of percutaneous ablation of bone metastases for pain palliation.

First author Year Ablation device No. of patients (no. of tumors) Mean tumor size (cm) Mean pain score change a No. of patients with reduced pain (%) Follow-up (mo)
Tanigawa 39 2018 RFA 33 (33) 6.1 6.1–1.3 (4.8/10) 23 (70) 12
Bagla 37 2016 RFA 50 (69) NR 5.9–2.1 (3.8/10) 34 (68) 3
Tomasian 41 2016 CA 14 (31) NR 8–3 (5/10) 14 (100) 10
Wallace 42 2015 RFA 72 (110) NR 8.0–2.9 (5.1/10) 45 of 58 (78) 1
Prologo 40 2014 CA 50 (54) NR 8 to 3 (5/10) 47 (94) 3
Callstrom 35 2013 CA 61 (69) 4.8 7.1–1.4 (5.7/10) 42 (69) 6
Pusceddu 44 2013 MWA 18 (21) 5.3 5.6–0.5 (5.1/10) 17 (94) 3
Kastler 46 2013 MWA 15 (25) 4.7 7.2–1.8 (5.4/10) 14 (93) 6
Dupuy 36 2010 RFA 55 (55) 5.2 NR (14.2/100) NR 3
Goetz 34 2004 RFA 43 (43) 6.3 7.9–1.4 (6.5/10) 41 (95) 6

Abbreviations: CA, cryoablation; MWA, microwave ablation; NR, not reported; RFA, radiofrequency ablation.

a

Mean score for maximal pain (mean score reduction/total points of pain scale used).